AIDS Prevention
New AIDS cases per 100,000 population age 13+
Management of HIV/AIDS
HIV-infection deaths per 100,000 population
HIV patients with CD4 counts less than 200 who received PCP prophylaxis
HIV patients with CD4 counts less than 50 who received MAC prophylaxis
New AIDS cases per 100,000 population age 13 and over.
Healthy People 2010, measure 13-1.
57. New AIDS cases per 100,000 population age 13 and over, United States, 2004, by
Centers for Disease Control, National HIV/AIDS Surveillance System.
U.S. resident population: adolescents and adults age 13 and over.
Number of reported new AIDS cases among adolescents and adults age 13 and over.
The AIDS case definition used by the HIV/AIDS Surveillance System for an AIDS case is provided by the CDC. Data are adjusted for reporting delay.
CDC Adult HIV/AIDS Confidential Case Report, Form 50.42A, Rev. 7/93
HIV-infection deaths per 100,000 population.
Healthy People 2010, measure 13-14.
58. HIV-infection deaths per 100,000 population, United States, 2003, by
Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System—Mortality.
U.S. resident population.
Number of deaths due to HIV infection (ICD-10-CM codes B20–B24).
Data are age adjusted to the 2000 standard population. Age-adjusted rates are weighted sums of age-specific rates. Resident death data are based on information from death certificates filed in the 50 States and the District of Columbia.
HIV patients with CD4 counts less than 200 who received Pneumocystis jiroveci pneumonia (PCP) prophylaxis.
The HIV Research Network.
59. HIV patients age 18 and over with CD4 cell count less than 200 who received PCP prophylaxis, United States, 2003, by
HIV Research Network, sponsored by multiple Federal agencies: the Agency for Healthcare Research and Quality (AHRQ), the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration (SAMHSA), the HIV/AIDS Bureau in the Health Resources and Services Administration (HRSA), and the Office of AIDS Research in the Office of the Director of the National Institutes of Health (OAR/NIH).
Patients diagnosed with HIV with CD4 counts < 200 cells/mm.
Subset of denominator who received PCP prophylactic therapy.
The taxonomy of the PCP organism has been changed; Pneumocystis jiroveci refers to the distinct species that infects humans. The abbreviation PCP is still used to designate Pneumocystis pneumonia.
For further information see Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004; 53 (No. RR-15): available from the CDC Web site at http://www.cdc.gov/mmwr/.
HIV patients with CD4 counts less than 50 who received Mycobacterium avium complex (MAC) prophylaxis.
The HIV Research Network.
60. HIV patients age 18 and over with CD4 cell count less than 50 who received MAC prophylaxis, United States, 2003, by
HIV Research Network, sponsored by multiple Federal agencies: the Agency for Healthcare Research and Quality (AHRQ), the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration (SAMHSA), the HIV/AIDS Bureau in the Health Resources and Services Administration (HRSA), and the Office of AIDS Research in the Office of the Director of the National Institutes of Health (OAR/NIH).
Patients diagnosed with HIV with CD4 counts < 50 cells/mm.
Subset of denominator who received MAC prophylactic therapy.
For further information see Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 2004; 53 (No. RR-15): available from the CDC Web site at http://www.cdc.gov/mmwr/.